ANG Lifesciences India Limited (BOM:540694)
India · Delayed Price · Currency is INR 40.27
+0.78 (1.98%)
At close: Sep 25, 2026
ANG Lifesciences India Market Cap
ANG Lifesciences India has a market cap or net worth of 525.86 million as of September 25, 2026. Its market cap has increased by 12.14% in one year.
Market Cap
525.86M
Enterprise Value
1.28B
Revenue
835.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.27
ChartMarket Cap Chart
Since September 8, 2017, ANG Lifesciences India's market cap has increased from 497.60M to 525.86M, an increase of 5.68%. That is a compound annual growth rate of 0.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 525.86M | 36.28% |
| Dec 31, 2025 | 385.87M | -33.77% |
| Dec 31, 2024 | 582.66M | -35.72% |
| Dec 29, 2023 | 906.38M | -42.23% |
| Dec 30, 2022 | 1.57B | -67.78% |
| Dec 31, 2021 | 4.87B | 1,136.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Source Natural Foods and Herbal Supplements | 701.30M |
| Onyx Biotec | 652.76M |
| Shelter Pharma | 627.17M |
| Phaarmasia | 611.35M |
| Cian Healthcare | 565.50M |
| Rekvina Laboratories | 554.68M |
| Biofil Chemicals and Pharmaceuticals | 522.06M |
| Mangalam Drugs & Organics | 504.92M |